Catalyst Funds Management Pty LTD Editas Medicine, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 14,100 shares of EDIT stock, worth $41,736. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,100Holding current value
$41,736% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EDIT
# of Institutions
240Shares Held
56.4MCall Options Held
488KPut Options Held
401K-
Black Rock Inc. New York, NY7.78MShares$23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.68MShares$19.8 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.9MShares$14.5 Million0.62% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.35MShares$9.92 Million0.01% of portfolio
-
State Street Corp Boston, MA2.46MShares$7.29 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $203M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...